The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy

Main Article Content

S. Barberi
G. Traina
M. Landi
G. De Castro
D. Peroni
A. Licari
G. Marseglia
G. Ciprandi

Keywords

N/A

Abstract

N/A

Abstract 300 | PDF Downloads 269

References

1. Del-Río Camacho G, Montes Arjona AM, Fernández-Cantalejo Padial J, Rodríguez Catalán J. How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollenallergic children. Allergol Immunopathol. 2018;46:552-6.

2. Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosign MV, Mahillo I. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy. 2012;67:709-11.

3. Ciprandi G, Scala E, Ariano R. Phleum pratense molecular pattern across Italy. Eur Annals Allergy Clin Immunol. 2017;49:176-80.

4. Ciprandi G, Silvestri M, Tosca MA. Combo-VAS: an integrated outcome for assessing the perception of allergen immunotherapy effectiveness in clinical practice. Annals Allegy Asthma Immunol. 2018;121:504-6.